1 2 UNITED STATES DISTRICT COURT 3 NORTHERN DISTRICT OF CALIFORNIA
5 THOMAS SANDYS, Case Nos. 20-cv-05480-PJH; 20-cv- 6 Plaintiff, 06041-PJH.
7 v. ORDER GRANTING MOTION TO 8 HOWARD A. WILLARD, et al., CONSOLIDATE, GRANTING MOTION TO TRANSFER, DENYING MOTION 9 Defendants. TO STAY, DENYING REQUEST TO APPOINT LEAD PLAINTIFF 10 MARIA CECILIA LORCA, Re: Dkt. Nos. 31, 32, 46, 51, 56 11 Plaintiff, 12 v. 13 WILLIAM F. GIFFORD, et. al., 14 Defendants. 15 16 17 Before the court is nominal defendant Altria Group, Inc.’s (“Altria”) as well as 18 defendants William F. Gifford Jr. (“Gifford”), Howard A. Willard III (“Willard”), and Kevin C. 19 Crosthwaite, Jr.’s (“Crosthwaite”) motion to transfer these related shareholder derivative 20 actions to the United States District Court for the Eastern District of Virginia’s Richmond 21 Division (the “Eastern District of Virginia”) or, in the alternative, enter a stay. 20-cv-5480 22 (the Sandys action), Dkt. 51; 20-cv-6041 (the Lorca action), Dkt. 32. Defendants Juul 23 Labs, Inc. (“Juul”) and Kevin Burns (“Burns”) join in the above motion. Dkt. 54. 24 Also before the court is plaintiff Thomas Sandys’ (“Sandys”) and Maria Lorca’s 25 (“Lorca”) (collectively, “plaintiffs”) motion to consolidate the above related actions and 26 appoint their selection of co-lead counsel. 20-cv-5480, Dkt. 46 (motion filed October 27, 27 2020); 20-cv-5480, Dkt. 56 (materially similar motion filed November 16, 2020); 20-cv- 1 materially similar. For purposes of this order, the court will cite only the Sandys docket 2 number (20-cv-5480) when referring to either motion. Given the overlap between the 3 complaint filed in Sandys and that in Lorca, the court will cite the Sandys complaint when 4 summarizing the relevant background information and cite the Lorca complaint only 5 where necessary. 6 Having read the parties’ papers and carefully considered their arguments and the 7 relevant legal authority, and good cause appearing, the court hereby GRANTS plaintiffs’ 8 motion to consolidate, GRANTS the Altria defendants’ motion to transfer, DENIES the 9 Altria defendants’ alternative motion to stay, and DENIES plaintiffs’ motion for 10 appointment of lead counsel. 11 BACKGROUND 12 Plaintiffs own shares in Altria. 20-cv-5480, Dkt. 1 (Sandys Compl.) ¶ 12; 20-cv- 13 6041, Dkt. 1 (Lorca Compl.) ¶ 19. On August 7, 2020, Sandys filed the instant 14 shareholder derivative action on Altria’s behalf against Willard, Gifford, and Crosthwaite, 15 as well as JUUL, Burns, Nicholas Pritzker (“Pritzker”), Riaz Valani (“Valani”). 16 Altria is a Virginia corporation that sells and distributes tobacco products. Sandys 17 Compl. ¶ 22. It owns the popular Marlboro cigarette brand. Id. ¶ 4. Willard was the chief 18 executive officer (“CEO”) of Altria between May 2018 and April 2020. Id. ¶ 13. Gifford 19 was the chief financial officer (“CFO”) of Altria and, following Willard’s retirement in April 20 2020, its CEO. Id. ¶ 14. Crosthwaite served as Altria’s Chief Growth Officer until 21 September 25, 2019, and, since that date, has served as JUUL’s CEO. Id. ¶ 15. For 22 purposes of this order, the court will refer to Willard, Gifford, and Crosthwaite (for the pre- 23 September 25, 2019 period) jointly as the “Altria defendants.” 24 At or around the time of this action’s initiation, JUUL was a San Francisco based 25 company that manufactures and sells vaping devices and products. Id. ¶ 20. Burns 26 served as JUUL’s CEO between December 11, 2017 and September 15, 2019. Id. ¶ 17. 27 Pritzker and Valani are both members of JUUL’s board of directors. Id. ¶¶ 18-19. The 1 24, 2019 period) jointly as the “JUUL defendants.” The court will refer to all defendants 2 as “defendants.” 3 I. Factual Background and the Instant Derivative Actions 4 Between 2017 and 2019, JUUL showed success in the e-cigarette market. Id. ¶ 3. 5 To reach such success, JUUL allegedly marketed its products to youth. Id. Seeing its 6 revenue from conventional cigarette sales decline, Altria sought to enter the e-cigarette 7 market. Id. ¶ 4. Altria’s early efforts proved unsuccessful. Id. Pivoting, Altria turned to 8 potentially acquire or otherwise partner with JUUL. Id. ¶¶ 5-7. 9 Sometime on or before December 2018, JUUL and Altria reached a deal on a 10 partnership that involved Altria cross-marketing JUUL products and licensing to JUUL 11 Altria’s own intellectual property. Id. ¶ 6. Sometime on or before December 20, 2018, 12 Altria invested $12.8 billion in JUUL in return for a 35 percent stake in JUUL. Id. ¶ 7. 13 By September 2019, following increased social and legal scrutiny of JUUL’s 14 marketing practices and vaping health risks, its value sharply decreased. Id. ¶ 8. That 15 decrease resulted in an $8 billion loss to Altria. Id. ¶ 72. 16 In his complaint, Sandys alleges the following two claims: 17 • Breach of fiduciary duty against the Altria defendants for failure to exercise due 18 care and good faith in managing the company’s affairs. Id. ¶¶ 124-28. 19 • Aiding and abetting breach of fiduciary duty, predicated on the above breaches 20 by the Altria defendants, against the JUUL defendants. Id. ¶¶ 129-31. 21 At core, Sandy’s theory of liability is that the Altria defendants breached their 22 duties to the company by doing business with JUUL when they knew and understood the 23 financial and legal risks that such partnering entailed. Id. ¶¶ 9-11, 62-72. Sandys further 24 alleges that there is “strong evidence” showing that Altria’s officers “colluded” with JUUL 25 in its purportedly illegal marketing practices and misrepresentations concerning the JUUL 26 vaping device’s safety, nicotine content, and use by youth. Id. ¶¶ 11, 73-91. Sandys also 27 alleges that the Altria defendants, through a tacit noncompete agreement with JUUL, 1 Altria to further regulatory liability, id. ¶ 92. 2 On August 27, 2020, twenty days after Sandys filed his action, Lorca filed her 3 action against defendants. In her complaint, Lorca alleges breach of fiduciary duty claims 4 against the Altria defendants, Lorca Compl. ¶¶ 124-28, as well as a claim for aiding and 5 abetting such breaches against the JUUL defendants, id. ¶¶ 129-32. Additionally, Lorca 6 alleges claims for corporate waste and unjust enrichment against the Altria defendants, 7 id. ¶¶ 134-41. 8 To substantiate her claims, Lorca relies on a theory of liability that is similar but not 9 identical to that advanced in Sandys. Like Sandys, Lorca alleges that the Altria 10 defendants breached their fiduciary duties to the company by entering the $12.8 billion 11 JUUL investment despite knowing that JUUL faced significant financial and legal risks. 12 Id. ¶¶ 48-63. Lorca similarly alleges that the Altria defendants participated in 13 anticompetitive behavior with JUUL, id. ¶¶ 64-72, and wrongfully acquiesced in JUUL’s 14 false and unlawful practice of marketing its products to youth, id. ¶¶ 42-47. 15 In addition to the above, Lorca adds that the Altria defendants made various 16 “improper statements” concerning Altria’s investment in JUUL. Id. ¶¶ 5, 36. According to 17 Lorca, the Altria defendants claimed that the JUUL investment would “accelerate JUUL’s 18 mission to switch adult smokers to e-vapor products,” endorsed JUUL’s products as 19 “potentially harm reductive,” and assured investors that JUUL was “committed to 20 preventing youth from using any tobacco products.” Id. ¶ 5. Lorca details the various 21 statements at issue, id. ¶¶ 73-106, as well as why they were improper, id. ¶ 107. 22 II. The Instant Motions 23 On November 16, 2020, the court related Lorca to Sandys and ordered the former 24 reassigned from Judge Richard Seeborg’s to the undersigned’s docket. 20-cv-5480, Dkt. 25 55.
Free access — add to your briefcase to read the full text and ask questions with AI
1 2 UNITED STATES DISTRICT COURT 3 NORTHERN DISTRICT OF CALIFORNIA
5 THOMAS SANDYS, Case Nos. 20-cv-05480-PJH; 20-cv- 6 Plaintiff, 06041-PJH.
7 v. ORDER GRANTING MOTION TO 8 HOWARD A. WILLARD, et al., CONSOLIDATE, GRANTING MOTION TO TRANSFER, DENYING MOTION 9 Defendants. TO STAY, DENYING REQUEST TO APPOINT LEAD PLAINTIFF 10 MARIA CECILIA LORCA, Re: Dkt. Nos. 31, 32, 46, 51, 56 11 Plaintiff, 12 v. 13 WILLIAM F. GIFFORD, et. al., 14 Defendants. 15 16 17 Before the court is nominal defendant Altria Group, Inc.’s (“Altria”) as well as 18 defendants William F. Gifford Jr. (“Gifford”), Howard A. Willard III (“Willard”), and Kevin C. 19 Crosthwaite, Jr.’s (“Crosthwaite”) motion to transfer these related shareholder derivative 20 actions to the United States District Court for the Eastern District of Virginia’s Richmond 21 Division (the “Eastern District of Virginia”) or, in the alternative, enter a stay. 20-cv-5480 22 (the Sandys action), Dkt. 51; 20-cv-6041 (the Lorca action), Dkt. 32. Defendants Juul 23 Labs, Inc. (“Juul”) and Kevin Burns (“Burns”) join in the above motion. Dkt. 54. 24 Also before the court is plaintiff Thomas Sandys’ (“Sandys”) and Maria Lorca’s 25 (“Lorca”) (collectively, “plaintiffs”) motion to consolidate the above related actions and 26 appoint their selection of co-lead counsel. 20-cv-5480, Dkt. 46 (motion filed October 27, 27 2020); 20-cv-5480, Dkt. 56 (materially similar motion filed November 16, 2020); 20-cv- 1 materially similar. For purposes of this order, the court will cite only the Sandys docket 2 number (20-cv-5480) when referring to either motion. Given the overlap between the 3 complaint filed in Sandys and that in Lorca, the court will cite the Sandys complaint when 4 summarizing the relevant background information and cite the Lorca complaint only 5 where necessary. 6 Having read the parties’ papers and carefully considered their arguments and the 7 relevant legal authority, and good cause appearing, the court hereby GRANTS plaintiffs’ 8 motion to consolidate, GRANTS the Altria defendants’ motion to transfer, DENIES the 9 Altria defendants’ alternative motion to stay, and DENIES plaintiffs’ motion for 10 appointment of lead counsel. 11 BACKGROUND 12 Plaintiffs own shares in Altria. 20-cv-5480, Dkt. 1 (Sandys Compl.) ¶ 12; 20-cv- 13 6041, Dkt. 1 (Lorca Compl.) ¶ 19. On August 7, 2020, Sandys filed the instant 14 shareholder derivative action on Altria’s behalf against Willard, Gifford, and Crosthwaite, 15 as well as JUUL, Burns, Nicholas Pritzker (“Pritzker”), Riaz Valani (“Valani”). 16 Altria is a Virginia corporation that sells and distributes tobacco products. Sandys 17 Compl. ¶ 22. It owns the popular Marlboro cigarette brand. Id. ¶ 4. Willard was the chief 18 executive officer (“CEO”) of Altria between May 2018 and April 2020. Id. ¶ 13. Gifford 19 was the chief financial officer (“CFO”) of Altria and, following Willard’s retirement in April 20 2020, its CEO. Id. ¶ 14. Crosthwaite served as Altria’s Chief Growth Officer until 21 September 25, 2019, and, since that date, has served as JUUL’s CEO. Id. ¶ 15. For 22 purposes of this order, the court will refer to Willard, Gifford, and Crosthwaite (for the pre- 23 September 25, 2019 period) jointly as the “Altria defendants.” 24 At or around the time of this action’s initiation, JUUL was a San Francisco based 25 company that manufactures and sells vaping devices and products. Id. ¶ 20. Burns 26 served as JUUL’s CEO between December 11, 2017 and September 15, 2019. Id. ¶ 17. 27 Pritzker and Valani are both members of JUUL’s board of directors. Id. ¶¶ 18-19. The 1 24, 2019 period) jointly as the “JUUL defendants.” The court will refer to all defendants 2 as “defendants.” 3 I. Factual Background and the Instant Derivative Actions 4 Between 2017 and 2019, JUUL showed success in the e-cigarette market. Id. ¶ 3. 5 To reach such success, JUUL allegedly marketed its products to youth. Id. Seeing its 6 revenue from conventional cigarette sales decline, Altria sought to enter the e-cigarette 7 market. Id. ¶ 4. Altria’s early efforts proved unsuccessful. Id. Pivoting, Altria turned to 8 potentially acquire or otherwise partner with JUUL. Id. ¶¶ 5-7. 9 Sometime on or before December 2018, JUUL and Altria reached a deal on a 10 partnership that involved Altria cross-marketing JUUL products and licensing to JUUL 11 Altria’s own intellectual property. Id. ¶ 6. Sometime on or before December 20, 2018, 12 Altria invested $12.8 billion in JUUL in return for a 35 percent stake in JUUL. Id. ¶ 7. 13 By September 2019, following increased social and legal scrutiny of JUUL’s 14 marketing practices and vaping health risks, its value sharply decreased. Id. ¶ 8. That 15 decrease resulted in an $8 billion loss to Altria. Id. ¶ 72. 16 In his complaint, Sandys alleges the following two claims: 17 • Breach of fiduciary duty against the Altria defendants for failure to exercise due 18 care and good faith in managing the company’s affairs. Id. ¶¶ 124-28. 19 • Aiding and abetting breach of fiduciary duty, predicated on the above breaches 20 by the Altria defendants, against the JUUL defendants. Id. ¶¶ 129-31. 21 At core, Sandy’s theory of liability is that the Altria defendants breached their 22 duties to the company by doing business with JUUL when they knew and understood the 23 financial and legal risks that such partnering entailed. Id. ¶¶ 9-11, 62-72. Sandys further 24 alleges that there is “strong evidence” showing that Altria’s officers “colluded” with JUUL 25 in its purportedly illegal marketing practices and misrepresentations concerning the JUUL 26 vaping device’s safety, nicotine content, and use by youth. Id. ¶¶ 11, 73-91. Sandys also 27 alleges that the Altria defendants, through a tacit noncompete agreement with JUUL, 1 Altria to further regulatory liability, id. ¶ 92. 2 On August 27, 2020, twenty days after Sandys filed his action, Lorca filed her 3 action against defendants. In her complaint, Lorca alleges breach of fiduciary duty claims 4 against the Altria defendants, Lorca Compl. ¶¶ 124-28, as well as a claim for aiding and 5 abetting such breaches against the JUUL defendants, id. ¶¶ 129-32. Additionally, Lorca 6 alleges claims for corporate waste and unjust enrichment against the Altria defendants, 7 id. ¶¶ 134-41. 8 To substantiate her claims, Lorca relies on a theory of liability that is similar but not 9 identical to that advanced in Sandys. Like Sandys, Lorca alleges that the Altria 10 defendants breached their fiduciary duties to the company by entering the $12.8 billion 11 JUUL investment despite knowing that JUUL faced significant financial and legal risks. 12 Id. ¶¶ 48-63. Lorca similarly alleges that the Altria defendants participated in 13 anticompetitive behavior with JUUL, id. ¶¶ 64-72, and wrongfully acquiesced in JUUL’s 14 false and unlawful practice of marketing its products to youth, id. ¶¶ 42-47. 15 In addition to the above, Lorca adds that the Altria defendants made various 16 “improper statements” concerning Altria’s investment in JUUL. Id. ¶¶ 5, 36. According to 17 Lorca, the Altria defendants claimed that the JUUL investment would “accelerate JUUL’s 18 mission to switch adult smokers to e-vapor products,” endorsed JUUL’s products as 19 “potentially harm reductive,” and assured investors that JUUL was “committed to 20 preventing youth from using any tobacco products.” Id. ¶ 5. Lorca details the various 21 statements at issue, id. ¶¶ 73-106, as well as why they were improper, id. ¶ 107. 22 II. The Instant Motions 23 On November 16, 2020, the court related Lorca to Sandys and ordered the former 24 reassigned from Judge Richard Seeborg’s to the undersigned’s docket. 20-cv-5480, Dkt. 25 55. Prior to that decision, on October 27, 2020, plaintiffs filed the instant motions to 26 consolidate these actions under Rule 42(a) and, pursuant to the court’s inherent 27 authority, “appoint plaintiffs’ co-lead counsel.” For whatever reason, plaintiffs refiled this 1 On November 10, 2020, the Altria defendants filed the instant motion to transfer 2 both Lorca and Sandys to the Eastern District of Virginia’s Richmond Division. 20-cv- 3 5480, Dkt. 51 (motion attaching original opening brief); 20-5480, Dkt. 53-1 (November 13, 4 2020 opening brief errata); 20-6041, Dkt. 32 (motion attaching opening brief); 20-6041, 5 Dkt. 34 (November 13, 2020 opening brief errata). JUUL and Burns joined Altria’s motion 6 in its entirety. Pritzker and Valani did not file a joinder or objection to Altria’s motion. 7 III. Related Litigation in Virginia and California 8 On October 1, 2020, a third Altria shareholder, plaintiff Eric Gilbert (“Gilbert”), filed 9 a derivative action against the Altria defendants, JUUL, Burns, and other defendants 10 (including Altria’s board of directors) in the Eastern District of Virginia. Judge David J. 11 Novak presides over that action, which is captioned Gilbert v. Gifford, et. al., No. 20-cv- 12 00772-DJN (E.D. Va.). Like plaintiffs, Gilbert alleges breach of fiduciary duty claims 13 against the Altria defendants as well as aiding and abetting claims against JUUL and 14 Burns. The court will detail the complaint in Gilbert as necessary in its analysis below. 15 On October 27, 2020, Gilbert and the appearing parties filed a joint motion to stay 16 the action pending Judge Novak’s decision on a motion to dismiss a separate action 17 against Altria alleging violations of the federal securities laws. 20-cv-00772-DJN (E.D. 18 Va), Dkt. 4 ¶. Judge Novak also presides over that federal securities action, which is 19 captioned Klein v. Altria Group, Inc., et. al., No. 20-cv-00075-DJN (E.D. Va.). 20 When filing their joint motion, the parties in Gilbert identified a fourth derivative 21 proceeding filed against the Altria’s board members in Virginia state court, captioned 22 Cohen v. Willard, et. al., No. CL20-7051 (Va. Cir. Ct. Henrico Cty.). Based on that 23 motion, it appears that state court stayed Cohen. The court need not detail Cohen to 24 decide the instant motion to transfer. 25 On October 29, 2020, Judge Novak entered a docket order in the Gilbert action 26 stating the following in relevant part: 27 This case is hereby STAYED pending resolution of the shall submit a proposed schedule to the Court regarding the 1 filing of any amended complaint, any responses thereto and the status of the Board's inquiry into the allegations contained in 2 Plaintiff's demand. 20-cv-00772-DJN (E.D. Va), Dkt. 10. 3 On March 12, 2021, Judge Novak filed an order in Klein largely denying the 4 above-referenced motions to dismiss. 20-cv-00075-DJN (E.D. Va.), Dkt. 139. 5 Separate from the Virginia actions, JUUL, Altria, and various individuals 6 associated with each entity have faced significant litigation across the country concerning 7 JUUL’s vaping products. In this district, Judge William Orrick presides over two actions 8 relevant to the instant motion to transfer—namely (1) a multidistrict litigation action 9 captioned In re Juul Labs, Inc., Marketing, Sales Practices, and Products Liability 10 Litigation, No. 19-md-02913-WHO (N.D. Cal); and (2) a related antitrust action In re Juul 11 Labs, Inc. Antitrust Litigation, No. 20-cv-02345-WHO (N.D. Cal.). Further, in Los Angeles 12 County Superior Court, Judge Ann I. Jones presides over a California Judicial Council 13 Coordinated Proceeding (“JCCP”) comprising over 2,000 personal injury plaintiffs. See 14 19-02913, Dkt. 1154 at 2 (In re JUUL November 18, 2020 joint CMC statement detailing 15 the same). Discovery in the Judge Orrick’s MDL action is underway. Id. at 6-7; 20-cv- 16 5480, Dkt. 64 (Plaintiffs’ December 14, 2020 Notice re New Factual Developments); 20- 17 cv-5480, Dkt. 66 (Plaintiffs’ March 16, 2021 Notice re New Factual Developments). 18 The court will detail the above actions as necessary in its analysis below. 19 DISCUSSION 20 I. Motion to Consolidate 21 A court may consolidate multiple actions on its docket if such actions involve a 22 common question of law or fact. Fed. R. Civ. Pro. 42(a)(2). A court’s decision to 23 consolidate under Rule 42(a) is “discretionary.” A. J. Indus., Inc. v. U.S. Dist. Ct. for 24 Cent. Dist. of California, 503 F.2d 384, 389 (9th Cir. 1974). 25 Both Sandys and Lorca assert claims for breach of fiduciary duty against the Altria 26 defendants and claims for aiding and abetting such breach against the JUUL defendants. 27 Compare Sandys Compl. ¶¶ 124-31 with Lorca Compl. ¶¶ 124-32. Both sets of claims 1 attempt to hold the Altria defendants liable for entering into the JUUL investment despite 2 knowing that JUUL faced significant financial and legal risks. Compare Sandys Compl. 3 ¶¶ 9-11, 62-72 with Lorca Compl. ¶¶ 48-63. They also rest on similar allegations that the 4 Altria defendants participated in anticompetitive behavior and wrongfully acquiesced in 5 JUUL’s unlawful practice of marketing its products to youth. Compare Sandys Compl. ¶¶ 6 11, 73-91, 93-109 with Lorca Compl. ¶¶ 42-47, 64-72. Separately, all answering parties 7 agree that consolidation is proper. Dkt. 46 at 7-8; Dkt. 53-1 at 13; Dkt. 54 at 2. 8 Given the above, the court will consolidate Sandys and Lorca. 9 II. Motion to Transfer or, Alternatively, Stay 10 Title 28 U.S.C. § 1404(a) provides the following in relevant part: 11 For the convenience of parties and witnesses, in the interest of justice, a district court may transfer any civil action to any other 12 district or division where it might have been brought. 28 U.S.C. § 1404(a). 13 14 A court may transfer an action under § 1404(a) only if it makes two findings. First, 15 the court must determine that “the action is one that might have been brought in the 16 transferee court.” Thermolife Int'l, LLC v. Vital Pharm., Inc., 2014 WL 12235190, at *2 17 (C.D. Cal. Aug. 15, 2014). Second, the court must conclude that “the convenience of the 18 parties and the interest of justice favor the transfer.” Id. 19 The party moving for transfer bears the burden of showing that the requested 20 transfer is proper. Ctr. for Biological Diversity v. Exp.-Imp. Bank of the United States, 21 2013 WL 5273088, at *4 (N.D. Cal. Sept. 17, 2013). Courts have broad discretion when 22 adjudicating motions to transfer. Ctr. for Biological Diversity v. Kempthorne, 2008 WL 23 453043, at *2 (N.D. Cal. Oct. 10, 2008). 24 For the reasons provided below, the court finds that the Altria defendants have 25 demonstrated that transfer is proper. 26 A. Plaintiffs Could Have Filed This Action in the Eastern District of 27 Virginia 1 brought in federal court. It provides that: 2 Any civil action by a stockholder on behalf of his corporation may be prosecuted in any judicial district where the corporation 3 might have sued the same defendants. 28 U.S.C. § 1401. 4 More generally, § 1391 provides that “[a] civil action may be brought in:” 5 a judicial district in which a substantial part of the events or omissions giving rise to the claim occurred, or a substantial part 6 of property that is the subject of the action is situated. 28 U.S.C. § 1391(b)(2). 7 8 The court finds that plaintiffs might have brought this consolidated action in the 9 Eastern District of Virginia. According to the declaration of Altria’s Vice President and 10 Treasurer, Daniel J. Bryant (“Bryant”), Altria and its management considered, made, and 11 implemented its decision to invest in JUUL from Altria’s Richmond, Virginia headquarters. 12 Dkt. 51-1 ¶¶ 5-9. Willard and Gifford both work in the headquarters and participated in 13 that decision. Id. ¶ 6. Given that management’s decision to invest in JUUL serves as 14 the basis for plaintiff’s claims for breach of fiduciary duty, the court finds that a significant 15 part of the events giving rise to plaintiff’s core claims occurred in Richmond. 16 However, whether plaintiffs could have brought their claims for aiding and abetting 17 the above-referenced breaches of fiduciary duty against the JUUL defendants in the 18 Eastern District of Virginia is a closer question. By virtue of their joinder to Altria’s motion 19 to transfer, JUUL and Burns have consented (and, presumably, would have consented) 20 to that court exercising personal jurisdiction over them. That leaves Pritzker and Valani. 21 Both of these defendants have appeared in this action. Dkt. 44 (Pritzker waiver of 22 service); Dkt. 45 (Valani waiver of service); Dkt. 59 (signed parties’ stipulation). Despite 23 that, neither defendant filed any indication of its position on the requested transfer. In its 24 opposition, plaintiffs fail to address whether the Eastern District of Virginia could, in the 25 first instance, even exercise personal jurisdiction over these defendants. Instead, 26 plaintiffs footnote that they “do not dispute that the Eastern District of Virginia may also 27 be a proper venue for the prosecution of the derivative claims . . .” Dkt. 62 at 17 n.10. 1 According to plaintiffs, both these defendants took on additional roles, including actively 2 managing JUUL and leading JUUL’s negotiations with Altria alongside Burns (JUUL’s 3 CEO). Sandys Compl. ¶ 110. Burns (a California resident, id. ¶ 27) is named as a 4 defendant for his role in purportedly aiding and abetting the alleged breaches of fiduciary 5 duties at issue in Gilbert. Thus, it appears that Pritzker and Valani are similarly situated 6 to Burns for purposes of a personal jurisdiction analysis. Given that, the court finds that 7 the claims for aiding and abetting against Prizker and Valani could also have been 8 brought in the Eastern District of Virginia. The court adds that this conclusion is 9 particularly appropriate where, as here, Pritzker and Valani both chose not to object to 10 the motion to transfer on grounds of personal jurisdiction (or otherwise). 11 In light of the above, the court concludes that plaintiffs may have brought this 12 consolidated action in the Eastern District of Virginia. 13 B. The Interest of Justice and Convenience Factors Favor Transfer 14 By its text, title 28 U.S.C. § 1404(a) identifies three types of concerns as relevant 15 to a court's discretionary transfer determination: (1) the convenience of the parties; (2) 16 the convenience of the witnesses; and (3) the interest of justice. 28 U.S.C. § 1404(a). 17 When analyzing those concerns, the Ninth Circuit has instructed district courts to 18 consider various non-exhaustive factors. Jones v. GNC Franchising, Inc., 211 F.3d 495, 19 498-99 (9th Cir. 2000). In relevant part, such factors include the following: 20 1. The plaintiff's chosen forum. 21 2. The parties' contacts with the forum. 22 3. The contacts relating to the claims in the chosen forum. 23 4. The differences in litigation costs between the two forums. 24 5. The ease of access to sources of proof. 25 6. The judicial district that is most familiar with the governing law. Id. 26 Further, the Ninth Circuit has also characterized the possible consolidation of 27 actions across judicial districts as a “significant factor” in a court’s transfer decision. A. J. 1 transfer decision . . .”). Lastly, courts may also consider any “local interest” in the subject 2 controversy as well as the “relative congestion” of the relevant venues. Ctr. for Biological 3 Diversity, 2013 WL 5273088 at *4. 4 For the reasons provided below, the court finds that the above factors clearly favor 5 transfer to the Eastern District of Virginia. 6 1. This Action’s Consolidation with Gilbert Appears Feasible 7 As previously mentioned, there are two actions pending in Virginia that assert 8 derivative claims against the Altria defendants, namely Gilbert v. Gifford, et. al., No. 3:20- 9 cv-0772 (E.D. Va.) and Cohen v. Willard, et. al., No. CL-20-7061 (Va. Cir. Ct. Henrico 10 Cty). The Altria defendants argue that Gilbert is a “substantially identical derivative action 11 arising from the same operative facts.” Dkt. 53-1 at 17. Plaintiffs do not disagree. 12 The court reviewed the complaint in Gilbert. In it, Gilbert appears to allege three 13 principal theories in support of his breach of fiduciary duty claims against the Altria 14 defendants. 20-cv-0772, Dkt. 1 (Gilbert Compl.) ¶¶ 223-26. First, Gilbert alleges that the 15 Altria defendants violated their duty of good faith to the company by recommending “an 16 investment in JUUL in the face of known risks.” Id. ¶¶ 140, 143-51. Second, Gilbert 17 alleges that these defendants “knew about JUUL’s misrepresentations and illegal 18 marketing,” participated in such conduct, and thus “made Altria liable for disseminating 19 misleading misrepresentations of JUUL’s nicotine content and safey[] and exposed Altria 20 to liability for promoting use among youth users.” Id. ¶¶ 141, 152-58. Third, Gilbert 21 alleges that the Altria defendants wrongfully exposed Altria to liability by engaging in 22 unfair trade practices with JUUL. Id. ¶¶ 142, 170-84. 23 Gilbert further adds that the Altria defendants made false and misleading 24 statements similar to those identified by Lorca in her complaint. Compare Id. ¶¶ 186-218 25 with Lorca Compl. ¶¶ 73-107. Lastly, Gilbert also alleges an ancillary claim for aiding and 26 abetting the above-referenced breaches of fiduciary duty against JUUL, Burns, and other 27 JUUL directors and officers. Gilbert Compl. ¶¶ 232-36. The court notes, however, that 1 defendants). 2 Based on the above-identified similarities between Gilbert and the instant action, 3 the court finds it possible that, if transferred to the Eastern District of Virginia, Judge 4 Novak would consolidate this action with Gilbert. 5 2. The Relevant Jones Factors Cut in Favor of Transfer 6 The court also finds that the relevant Jones factors cut in favor of transfer. 7 a. Plaintiffs’ Choice of Forum Is Entitled to Little Weight 8 Plaintiffs are correct that, in the ordinary course, their choice of forum is entitled to 9 deference. Dkt. 62 at 18-19. However, as the Altria defendants point out, the instant 10 action is not ordinary. Dkt. 53-1 at 16. Rather, it is a derivative action brought on behalf 11 of Altria for purported harms that the company suffered as a result of the alleged 12 breaches of fiduciary duties. 13 The Ninth Circuit has ruled that “[w]hen an individual brings a derivative suit or 14 represents a class, the named plaintiff's choice of forum is given less weight.” Lou v. 15 Belzberg, 834 F.2d 730, 739 (9th Cir. 1987). The Ninth Circuit has also explained that 16 “[i]n judging the weight to be accorded [plaintiff’s] choice of forum, consideration must be 17 given to the extent of both [plaintiff’s] and [defendants’] contacts with the forum, including 18 those relating to [plaintiff’s] cause of action. . . . If the operative facts have not occurred 19 within the forum and the forum has no interest in the parties or subject matter, [plaintiff’s] 20 choice is entitled to only minimal consideration.” Id. 21 In their complaints, neither plaintiff alleges any contact with California. Given that 22 Sandys is an Ohio resident, Sandys Compl. ¶ 24, and Lorca is a Florida resident, Lorca 23 Compl. ¶ 19, the court will infer that neither plaintiff, in fact, had any such contact. While 24 Sandys does allege at least some part of the JUUL investment negotiations occurred in 25 San Francisco, such contact appears vague. Sandys Compl. ¶ 32 (“At least one, likely 26 several, negotiation sessions were conducted in San Francisco, California . . . Willard, at 27 least on one instance, visited JUUL headquarters in San Francisco . . . in conduct 1 . . Willard and Gifford both communicated with JUUL Defendant when JUUL Defendants 2 were located in California . . .”). In any event, when weighed against real party in interest 3 Altria’s stated preference for litigating this action in its home state of Virginia, Dkt. 53-1 at 4 16, the court finds such contacts insufficient to warrant deference to plaintiffs’ choice of 5 forum.1 6 b. The Convenience-Related Factors Favor Transfer 7 In his declaration, Bryant identifies over a dozen Altria personnel who both 8 participated in the company’s decision to invest in JUUL and reside or work in Virginia. 9 Dkt. 51-1 ¶¶ 6-9. That decision is at the core of plaintiffs’ breach of fiduciary duty claims. 10 Thus, to the extent plaintiffs’ complaint survives a motion to dismiss, such personnel’s 11 depositions and potential trial testimony should be relevant to plaintiffs’ claims. Given the 12 relevant personnel’s location, the court finds that the requested transfer would improve 13 access to the relevant proof and likely decrease litigation costs.2 14 Neither of plaintiffs’ principal contentions alter that finding. First, plaintiffs 15 insistently cite the JUUL actions pending in this district to support its argument that 16 California is the more convenient forum. Dkt. 62 at 19-20. However, when making that 17 argument, plaintiffs fail to explain how or why the discovery presently underway in either 18 action could be used in the instant derivative action to streamline proof issues and 19 mitigate costs. In any event, even if plaintiffs had, the JUUL actions in this district are 20 before Judge Orrick, not the undersigned. Despite five months on the undersigned’s 21 docket, plaintiffs have not moved to relate either action to Judge Orrick’s MDL. Thus, to 22 the extent there could be any cost savings by keeping this action in this district, the court 23 cannot see how, in practice, they would be realized. 24 1 The court disagrees with plaintiffs’ suggestion that Altria has no preference because it 25 “has not[] enacted an exclusive forum clause directing that all derivative actions be brought in Virginia.” Dkt. 62 at 19 n.14. Plaintiffs fail to cite any Virginia authority to 26 support the contention that a company must formally adopt such a bylaw to express a cognizable interest in its preferred place of litigation. 27 2 The court agrees with plaintiffs that the location of documents is a nullity. Defendants 1 Second, plaintiffs argue that the convenience factor cuts against transfer because 2 some of the JUUL defendants reside in California. Dkt. 62 at 19. That argument gets it 3 backwards. The instant consolidated action principally alleges breach of fiduciary duty 4 claims against the Altria defendants. Indeed, to maintain its aiding and abetting claim 5 against the JUUL defendants (to the extent that claim is even cognizable under Virginia 6 law), plaintiff must first show a predicate breach of a fiduciary duty by the Altria 7 defendants. Thus, it appears that most factual development (if any) in this action will 8 focus on the Altria defendants, not their JUUL counterparts. Given that, the court will 9 assign more convenience value to their preferred place of litigation. 10 In any event, by virtue of their joinder to the instant motion to transfer, neither 11 JUUL nor Burns can complain of any “inconvenience” from having to litigate this action 12 outside California. Given that neither plaintiff is a California resident, the court finds the 13 same with respect to them. In light of the above, the court concludes that the 14 convenience factors favor transfer to the Eastern District of Virginia. 15 c. The Eastern District of Virginia Is More Familiar with the 16 Applicable Corporate Law 17 In their respective complaints, plaintiffs allege their breach of fiduciary duty claims 18 under Virginia law. Sandys Compl. ¶¶ 36-38; Lorca Compl. ¶ 121 (citing demand letter 19 for the proposition that “since Altria is incorporated in Virginia, Virginia's laws regarding 20 shareholder litigation demands and derivative actions apply to the Board.”). Neither 21 plaintiff indicates in their complaint that their aiding and abetting claims rest on California 22 law. Thus, Virginia law appears to control this consolidated action in its entirety. 23 While this court is more than capable of interpreting and applying Virginia law, the 24 Eastern District of Virginia plainly has more familiarity with its own state’s substantive law. 25 Accordingly, the court finds that this remaining Jones factor cuts in favor of transfer. 26 3. Local Interest Cuts in Favor of Transfer 27 Both California and Virginia have an interest in the substance of this litigation. As 1 handling a complex multidistrict litigation action brought by over a thousand plaintiffs 2 alleging claims against JUUL, Altria, and others for unlawful business practices premised 3 on JUUL’s “past conduct that center on intentional youth marketing or negligent 4 knowledge but encouragement of youth use of its products . . .” In re JUUL Labs, Inc., 5 Mktg., Sales Practices, & Prod. Liab. Litig., -- F.Supp. 3d --, 2020 WL 6271173, at *7 6 (N.D. Cal. Oct. 23, 2020). Judge Orrick also presides over a related consolidated 7 antitrust action, In re Juul Labs, Inc. Antitrust Litigation, No. 20-cv-02345-WHO (N.D. 8 Cal.). That said, the primary focus of both litigations appears to be on JUUL, which, at 9 the time of the MDL’s filing, was a Delaware corporation with its principal place of 10 business in San Francisco. 11 Altria, on the other hand, is a Virginia corporation with its principal place of 12 business in Virginia. Sandys Compl. ¶ 22. Like California’s interest in actions against 13 companies headquartered in its state, Virginia has an interest in plaintiffs’ action against 14 Altria. Moreover, the Altria defendants proffered evidence showing that the decisions 15 underlying the breach of fiduciary duty claims at issue occurred at Altria’s headquarters in 16 Richmond. Dkt. 51-1 ¶¶ 5-14. Given the above, the court finds that this final factor cuts 17 in favor of transfer.3 18 * * * 19 For the above reasons, the court will transfer this consolidated action to the 20 Eastern District of Virginia’s Richmond Division. Given that decision, the court need not 21 decide the Altria defendants’ alternative motion to stay. Because the court will no longer 22 maintain jurisdiction over this action, it will abstain from making any “lead counsel” 23 determination. Accordingly, the court denies both remaining motions without prejudice. 24 CONCLUSION 25 For the above reasons, the court GRANTS plaintiffs’ motion to consolidate Sandys 26 and Lorca. 20-cv-5480, Dkt. 46; 20-cv-5480, Dkt. 56; 20-cv-6041, Dkt. 31. The court 27 1 also DENIES plaintiffs’ request to appoint lead counsel. Id. Further, the court GRANTS 2 the Altria defendants’ motion to transfer and DENIES their alternative request to stay the 3 instant litigation. 20-cv-5480, Dkt. 51; 20-cv-6041, Dkt. 32. The court directs the clerk to 4 consolidate and then transfer this action to the United States District Court for the 5 Eastern District of Virginia’s Richmond Division. 6 IT IS SO ORDERED. 7 Dated: March 22, 2021 8 /s/ Phyllis J. Hamilton PHYLLIS J. HAMILTON 9 United States District Judge 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27